Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Plethora Solutions Holdings PLC's Prilocaine Lidocaine Plethora Receives Authorisation from European Commission


Tuesday, 19 Nov 2013 02:00am EST 

Plethora Solutions Holdings PLC announced that the European Commission has granted marketing authorisation for the Company's treatment for primary premature ejaculation in adult men under the name Prilocaine Lidocaine Plethora. This product is also referred to by the Company under its development code PSD502. 

Company Quote

6.75
-0.125 -1.82%
24 Oct 2014